Page last updated: 2024-09-03

cp 65,526 and osi 930

cp 65,526 has been researched along with osi 930 in 1 studies

Compound Research Comparison

Studies
(cp 65,526)
Trials
(cp 65,526)
Recent Studies (post-2010)
(cp 65,526)
Studies
(osi 930)
Trials
(osi 930)
Recent Studies (post-2010) (osi 930)
651527220

Protein Interaction Comparison

ProteinTaxonomycp 65,526 (IC50)osi 930 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.041
Tyrosine-protein kinase LckHomo sapiens (human)0.022
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.0195
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.007

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambudkar, SV; Chen, X; Chen, ZS; Dai, CL; Fu, LW; Korlipara, VL; Kuang, YH; Liao, LQ; Patel, A; Patel, JP; Sodani, K; Tiwari, AK; Wu, CP1

Other Studies

1 other study(ies) available for cp 65,526 and osi 930

ArticleYear
OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance.
    Biochemical pharmacology, 2012, Sep-15, Volume: 84, Issue:6

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Benzene Derivatives; Biological Transport; Cells, Cultured; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mitoxantrone; Neoplasm Proteins; Nitro Compounds; Photoaffinity Labels; Prazosin; Pyridines; Quinolines; Structure-Activity Relationship; Thiophenes; Transfection

2012